4//SEC Filing
Keswani Sanjay 4
Accession 0001567619-21-007084
CIK 0001528115other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 5:52 PM ET
Size
9.1 KB
Accession
0001567619-21-007084
Insider Transaction Report
Form 4
Annexon, Inc.ANNX
Keswani Sanjay Chandru
EVP & Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-03-24−3,995→ 182,956 totalExercise: $7.49Exp: 2029-06-20→ Common Stock (3,995 underlying) - Exercise/Conversion
Common Stock
2021-03-24$7.49/sh+3,995$29,917→ 3,995 total - Sale
Common Stock
2021-03-24$30.17/sh−3,995$120,512→ 0 total
Footnotes (3)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades in prices ranging from $30.00 to $30.49, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]25% of the shares subject to the option vest on the first anniversary measured from June 17, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
Annexon, Inc.
CIK 0001528115
Entity typeother
Related Parties
1- filerCIK 0001818524
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 5:52 PM ET
- Size
- 9.1 KB